From morning aches to chilly toes, uncover the common foot problems you may be missing—and find out how to keep your feet ...

"Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support ...

Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private placement Combined company will operate under the name “Pelthos Therapeutics Inc.” and will ...

An Omaha metro surgeon argues that tariffs on foreign-made pharmaceuticals would be catastrophic for his patients.

Medically reviewed by Oluseun Olufade, MD Lower back pain affects more than 80% of people at some point. It is especially ...

Plantar fasciitis, bunions, and arthritis are all among the common causes of foot pain. Learn what to do when your feet hurt and when to see a doctor.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has successfully completed its merger with Channel Therapeutics ...

Ligand Pharmaceuticals Inc. (LGND) and Pelthos Therapeutics Inc. announced Wednesday the closing of the previously announced merger agreement with Channel Therapeutics Corp.

Noninvasive brain stimulation techniques, including transcranial direct current stimulation, are effective nonpharmacologic treatments for insomnia.